- Home
- GANX vs TORO Comparison
GANX vs TORO Comparison
Compare GANX & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- TORO
- Stock Information
- Founded
- GANX 2017
- TORO 2022
- Country
- GANX United States
- TORO Cyprus
- Employees
- GANX N/A
- TORO N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- TORO Marine Transportation
- Sector
- GANX Health Care
- TORO Consumer Discretionary
- Exchange
- GANX Nasdaq
- TORO Nasdaq
- Market Cap
- GANX 79.8M
- TORO 78.4M
- IPO Year
- GANX 2021
- TORO N/A
- Fundamental
- Price
- GANX $1.76
- TORO $3.70
- Analyst Decision
- GANX Strong Buy
- TORO
- Analyst Count
- GANX 6
- TORO 0
- Target Price
- GANX $8.00
- TORO N/A
- AVG Volume (30 Days)
- GANX 901.0K
- TORO 73.9K
- Earning Date
- GANX 11-12-2025
- TORO 11-14-2025
- Dividend Yield
- GANX N/A
- TORO N/A
- EPS Growth
- GANX N/A
- TORO N/A
- EPS
- GANX N/A
- TORO 0.01
- Revenue
- GANX N/A
- TORO $20,143,992.00
- Revenue This Year
- GANX N/A
- TORO N/A
- Revenue Next Year
- GANX N/A
- TORO N/A
- P/E Ratio
- GANX N/A
- TORO $291.57
- Revenue Growth
- GANX N/A
- TORO 0.40
- 52 Week Low
- GANX $1.41
- TORO $1.70
- 52 Week High
- GANX $2.81
- TORO $4.94
- Technical
- Relative Strength Index (RSI)
- GANX 43.08
- TORO 47.95
- Support Level
- GANX $1.74
- TORO $3.76
- Resistance Level
- GANX $2.08
- TORO $4.19
- Average True Range (ATR)
- GANX 0.15
- TORO 0.16
- MACD
- GANX -0.03
- TORO -0.09
- Stochastic Oscillator
- GANX 5.26
- TORO 4.17
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.